Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 391 AL 405

Deciphering Molecular and Signaling Pathways of Extracellular Vesicles-Based Therapeutics for Alzheimer's Disease

Dhapola R, Kumari S, Sharma P, Paidlewar M, Medhi B, Vellingiri B, HariKrishnaReddy D.

Mol Neurobiol. 2025 Dec;62(12):15430-15449. doi: 10.1007/s12035-025-05216-6. Epub 2025 Jul 18.

Eriocitrin and its derivatives against Alzheimer's disease: Cumulative accounts of in vitro and in vivo studies

Kritika, Sanjay, Lee HJ.

Biomed Pharmacother. 2025 Sep;190:118362. doi: 10.1016/j.biopha.2025.118362. Epub 2025 Jul 21.

A novel therapeutic prospect: a dual-acting tirzepatide for Alzheimer's disease

Alshehri GH, Al-Kuraishy HM, Al-Gareeb AI, Fawzy MN, Waheed HJ, Papadakis M, Alexiou A, El-Saber Batiha G.

Eur J Pharmacol. 2025 Sep 15;1003:177979. doi: 10.1016/j.ejphar.2025.177979. Epub 2025 Jul 22.

Is dolichol pathway dysfunction a significant factor in Alzheimer's disease?

Schloss JV.

Inflammopharmacology. 2025 Aug;33(8):4651-4658. doi: 10.1007/s10787-025-01868-x. Epub 2025 Jul 25.

Understanding the Insulin-Degrading Enzyme: A New Look at Alzheimer's Disease and Aβ Plaque Management

Cerasuolo M, Auriemma MC, Di Meo I, Lenti C, Papa M, Paolisso G, Rizzo MR.

Int J Mol Sci. 2025 Jul 12;26(14):6693. doi: 10.3390/ijms26146693.

The role of peripheral innate immune cells in Alzheimer's disease progression

Cao Y, Tang K, Ma P, Zhang R, Yang Y, Li T, Zhang Y, Peng X.

Front Immunol. 2025 Jul 16;16:1616939. doi: 10.3389/fimmu.2025.1616939. eCollection 2025.

Exploring the Interconnections of Genetic, Lifestyle, and Epigenetic Influences on Brain Aging: A Comprehensive Review

Mehrabadi S, Barati S.

Curr Alzheimer Res. 2025;22(7):488-501. doi: 10.2174/0115672050393583250718145103.

Adaptive immunity in the neuroinflammation of Alzheimer's disease

Liu H, Chen Y, Zhang J, Chen X.

Chin Med J (Engl). 2025 Sep 5;138(17):2116-2129. doi: 10.1097/CM9.0000000000003695. Epub 2025 Aug 5.

Phytocompounds as modulators of HSF1 in neurodegenerative disease: Special emphasis on Alzheimer's disease

Nelson VK, Begum MY, Dera AA, Ali SP, Suryadevara PR.

Eur J Pharmacol. 2025 Oct 15;1005:178034. doi: 10.1016/j.ejphar.2025.178034. Epub 2025 Aug 5.

Management of sleep disturbance related to Alzheimer disease and dementia: An updated review of ClinicalTrials.gov

Aldurdunji MM.

Medicine (Baltimore). 2025 Aug 8;104(32):e43725. doi: 10.1097/MD.0000000000043725.

From APOE to cellular changes: Unraveling the multidimensional mechanisms of blood-brain barrier damage in Alzheimer's disease

Jiang F, Wang N, Meng Q.

J Alzheimers Dis. 2025 Sep;107(2):421-438. doi: 10.1177/13872877251360321. Epub 2025 Sep 1.

Clusterin Regulates the Mechanisms of Neuroinflammation and Neuronal Circuit Impairment in Alzheimer's Disease

Yu Y, Wang C, Wang B, Wang X, Zhao Q, Yan Y, Liu X.

Int J Mol Sci. 2025 Jul 28;26(15):7271. doi: 10.3390/ijms26157271.

Understanding the role of microglia in Alzheimer's disease: insights into mechanisms, acupuncture, and potential therapeutic targets

Jinglei J, Tao YU, Yulin Q, Meng W.

J Tradit Chin Med. 2025 Aug;45(4):922-936. doi: 10.19852/j.cnki.jtcm.20250327.002.

Rationale and emerging evidence for microglial replacement in Alzheimer's disease

Bang JY, Yoo Y.

Mol Cells. 2025 Oct;48(10):100265. doi: 10.1016/j.mocell.2025.100265. Epub 2025 Aug 14.

PANoptosis: Potential Therapeutic Prospects in Alzheimer's Disease

Guo Z, Wan Y.

Eur J Neurosci. 2025 Aug;62(4):e70231. doi: 10.1111/ejn.70231.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias